328130 — Lunit Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for Lunit, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,639	13,866	25,080	54,180	83,129
Cost of Revenue
Gross Profit	5,878	13,707	24,967	53,914	82,878
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	52,339	64,517	67,296	122,127	166,233
Operating Profit	-45,700	-50,651	-42,215	-67,947	-83,104
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-73,676	-39,118	-36,764	-83,502	-46,835
Provision for Income Taxes
Net Income After Taxes	-73,676	-39,118	-36,798	-82,695	-47,390
Net Income Before Extraordinary Items
Net Income	-73,676	-39,118	-36,798	-82,695	-47,390
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-73,676	-39,118	-36,798	-82,695	-47,390
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,533	-820	-670	-1,342	-761
Dividends per Share